Trial Outcomes & Findings for Neonatal Outcome by Reason for Delivery (NCT NCT01818518)

NCT ID: NCT01818518

Last Updated: 2019-06-18

Results Overview

The primary outcome is Composite Perinatal Morbidity. Composite morbidity refers to the newborns born to the female participants enrolled in the study. Composite Morbidity is defined as ≥ 1 of the following: respiratory distress syndrome (RDS) (oxygen requirement, clinical diagnosis, and consistent chest radiograph), bronchopulmonary dysplasia (BPD) (requirement for oxygen support at 28 days of life), severe intraventricular hemorrhage (IVH) (grades III or IV), periventricular leukomalacia (PVL), blood culture-proven sepsis present within 72 hours of birth, necrotising enterocolitis (NEC), or perinatal death (stillbirth or neonatal death prior to hospital discharge).

Recruitment status

COMPLETED

Target enrollment

995 participants

Primary outcome timeframe

Infants from birth until discharge or until infant reaches 28 days of life.

Results posted on

2019-06-18

Participant Flow

Participant milestones

Participant milestones
Measure
Prelabor Rupture of Membranes Diagnosis on Admission
Group who have prelabor rupture of membranes (PROM) are those who break their bag of water prior to 32 weeks gestation in the absence of labor. Diagnosis made on admission
Preterm Labor Diagnosis on Admission
Group who goes into labor prior to 32 weeks of gestation. Diagnosis was made on admission
Pre-eclampsia Diagnosis on Admission
The diagnosis of Preeclampsia at time of admission
Intrauterine Growth Restriction (IUGR) Diagnosis on Admission
The diagnosis of IUGR at time of admission
Vaginal Bleeding Diagnosis on Admission
The diagnosis of vaginal bleeding made at time of admission
Short Cervix Diagnosis on Admission
The diagnosis of Short cervical length at time of admission
Overall Study
STARTED
310
263
288
59
38
37
Overall Study
COMPLETED
310
263
288
59
38
37
Overall Study
NOT COMPLETED
0
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Prelabor Rupture of Membranes Diagnosis on Admission
n=310 Participants
Group who have prelabor rupture of membranes (PROM) are those who break their bag of water prior to 32 weeks gestation in the absence of labor. Diagnosis made on admission
Preterm Labor Diagnosis on Admission
n=263 Participants
Group who goes into labor prior to 32 weeks of gestation. Diagnosis was made on admission
Pre-eclampsia Diagnosis on Admission
n=288 Participants
The diagnosis of Preeclampsia at time of admission
IUGR Diagnosis on Admission
n=59 Participants
The diagnosis of IUGR at time of admission
Vaginal Bleeding Diagnosis on Admission
n=38 Participants
The diagnosis of vaginal bleeding made at time of admission
Short Cervix Diagnosis on Admission
n=37 Participants
The diagnosis of Short cervical length at time of admission
Total
n=995 Participants
Total of all reporting groups
Age, Continuous
29.7 years
STANDARD_DEVIATION 6.0 • n=310 Participants
28.1 years
STANDARD_DEVIATION 6.0 • n=263 Participants
29.9 years
STANDARD_DEVIATION 6.5 • n=288 Participants
28.6 years
STANDARD_DEVIATION 5.6 • n=59 Participants
28.9 years
STANDARD_DEVIATION 6.2 • n=38 Participants
29.4 years
STANDARD_DEVIATION 5.6 • n=37 Participants
29.1 years
STANDARD_DEVIATION 5.9 • n=995 Participants
Sex: Female, Male
Female
310 Participants
n=310 Participants
263 Participants
n=263 Participants
288 Participants
n=288 Participants
59 Participants
n=59 Participants
38 Participants
n=38 Participants
37 Participants
n=37 Participants
995 Participants
n=995 Participants
Sex: Female, Male
Male
0 Participants
n=310 Participants
0 Participants
n=263 Participants
0 Participants
n=288 Participants
0 Participants
n=59 Participants
0 Participants
n=38 Participants
0 Participants
n=37 Participants
0 Participants
n=995 Participants
Race/Ethnicity, Customized
White
163 Participants
n=299 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
139 Participants
n=257 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
142 Participants
n=284 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
33 Participants
n=59 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
21 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
19 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
517 Participants
n=971 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
Race/Ethnicity, Customized
Hispanic
67 Participants
n=299 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
51 Participants
n=257 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
61 Participants
n=284 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
9 Participants
n=59 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
4 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
5 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
197 Participants
n=971 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
Race/Ethnicity, Customized
Black
32 Participants
n=299 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
25 Participants
n=257 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
35 Participants
n=284 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
6 Participants
n=59 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
7 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
8 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
113 Participants
n=971 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
Race/Ethnicity, Customized
Asian
11 Participants
n=299 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
18 Participants
n=257 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
13 Participants
n=284 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
3 Participants
n=59 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
3 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
2 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
50 Participants
n=971 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
Race/Ethnicity, Customized
Other
37 Participants
n=299 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
30 Participants
n=257 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
37 Participants
n=284 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
8 Participants
n=59 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
3 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
3 Participants
n=36 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
118 Participants
n=971 Participants • Not all ethnicity data was available for all participants enrolled in the study and participants were able to select more than one Race/Ethnicity when applicable.
Region of Enrollment
United States
310 participants
n=310 Participants
263 participants
n=263 Participants
288 participants
n=288 Participants
59 participants
n=59 Participants
38 participants
n=38 Participants
37 participants
n=37 Participants
995 participants
n=995 Participants
Nulliparity
100 Participants
n=292 Participants • number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown.
108 Participants
n=255 Participants • number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown.
133 Participants
n=282 Participants • number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown.
22 Participants
n=59 Participants • number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown.
7 Participants
n=33 Participants • number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown.
17 Participants
n=35 Participants • number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown.
387 Participants
n=956 Participants • number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown.
Prenatal Care
290 Participants
n=298 Participants • Measure Analysis Population Description: number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown
247 Participants
n=255 Participants • Measure Analysis Population Description: number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown
273 Participants
n=284 Participants • Measure Analysis Population Description: number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown
57 Participants
n=59 Participants • Measure Analysis Population Description: number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown
34 Participants
n=36 Participants • Measure Analysis Population Description: number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown
33 Participants
n=36 Participants • Measure Analysis Population Description: number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown
934 Participants
n=968 Participants • Measure Analysis Population Description: number analyzed if different from total number because these characteristic were not captured on all patients. Some baseline data was unknown
Gestational Age at admission , wks
27.1 weeks
STANDARD_DEVIATION 2.7 • n=310 Participants
27.7 weeks
STANDARD_DEVIATION 2.6 • n=263 Participants
28.3 weeks
STANDARD_DEVIATION 2.2 • n=288 Participants
28.2 weeks
STANDARD_DEVIATION 2.3 • n=59 Participants
26.7 weeks
STANDARD_DEVIATION 2.9 • n=38 Participants
24.4 weeks
STANDARD_DEVIATION 2.3 • n=37 Participants
27.0 weeks
STANDARD_DEVIATION 2.5 • n=995 Participants
Gestational Age at delivery, wks
28.5 weeks
STANDARD_DEVIATION 2.5 • n=310 Participants
28.1 weeks
STANDARD_DEVIATION 2.5 • n=263 Participants
28.9 weeks
STANDARD_DEVIATION 2.1 • n=288 Participants
29.1 weeks
STANDARD_DEVIATION 2.2 • n=59 Participants
27.4 weeks
STANDARD_DEVIATION 2.6 • n=38 Participants
26.3 weeks
STANDARD_DEVIATION 2.6 • n=37 Participants
28.1 weeks
STANDARD_DEVIATION 2.4 • n=995 Participants
Interval from admission to delivery, wks.
1.4 weeks
STANDARD_DEVIATION 1.6 • n=310 Participants
0.4 weeks
STANDARD_DEVIATION 0.7 • n=263 Participants
0.6 weeks
STANDARD_DEVIATION 0.7 • n=288 Participants
0.9 weeks
STANDARD_DEVIATION 1.1 • n=59 Participants
0.7 weeks
STANDARD_DEVIATION 1.0 • n=38 Participants
1.8 weeks
STANDARD_DEVIATION 2.0 • n=37 Participants
1.0 weeks
STANDARD_DEVIATION 1.2 • n=995 Participants
Cesarean delivery
178 Participants
n=310 Participants
107 Participants
n=263 Participants
268 Participants
n=288 Participants
58 Participants
n=59 Participants
27 Participants
n=38 Participants
22 Participants
n=37 Participants
660 Participants
n=995 Participants
Received full course of antenatal corticosteroids
138 Participants
n=310 Participants
114 Participants
n=263 Participants
195 Participants
n=288 Participants
32 Participants
n=59 Participants
14 Participants
n=38 Participants
19 Participants
n=37 Participants
512 Participants
n=995 Participants
Male newborn
178 Participants
n=310 Participants
149 Participants
n=263 Participants
145 Participants
n=288 Participants
33 Participants
n=59 Participants
22 Participants
n=38 Participants
24 Participants
n=37 Participants
551 Participants
n=995 Participants
Primary reason for delivery = spontaneous labor
171 Participants
n=310 Participants
228 Participants
n=263 Participants
0 Participants
n=288 Participants
2 Participants
n=59 Participants
11 Participants
n=38 Participants
21 Participants
n=37 Participants
433 Participants
n=995 Participants
Primary reason for delivery = preeclampsia
0 Participants
n=310 Participants
0 Participants
n=263 Participants
219 Participants
n=288 Participants
3 Participants
n=59 Participants
0 Participants
n=38 Participants
0 Participants
n=37 Participants
222 Participants
n=995 Participants
Primary reason for delivery = fetal heart rate nonreassuring
54 Participants
n=310 Participants
15 Participants
n=263 Participants
49 Participants
n=288 Participants
42 Participants
n=59 Participants
7 Participants
n=38 Participants
6 Participants
n=37 Participants
173 Participants
n=995 Participants
Primary reason for delivery = chorioamnionitis
54 Participants
n=310 Participants
12 Participants
n=263 Participants
0 Participants
n=288 Participants
0 Participants
n=59 Participants
0 Participants
n=38 Participants
5 Participants
n=37 Participants
71 Participants
n=995 Participants
Primary reason for delivery = Bleeding
18 Participants
n=310 Participants
6 Participants
n=263 Participants
8 Participants
n=288 Participants
0 Participants
n=59 Participants
20 Participants
n=38 Participants
1 Participants
n=37 Participants
53 Participants
n=995 Participants
Primary reason for delivery = Other
13 Participants
n=310 Participants
2 Participants
n=263 Participants
12 Participants
n=288 Participants
12 Participants
n=59 Participants
0 Participants
n=38 Participants
4 Participants
n=37 Participants
43 Participants
n=995 Participants

PRIMARY outcome

Timeframe: Infants from birth until discharge or until infant reaches 28 days of life.

Population: Composite morbidity is defined as ≥ 1 of the following: RDS, BPD, severe IVH (grades III or IV), PVL, blood culture-proven sepsis present within 72 hours of birth, NEC, or perinatal death. Perinatal Morbidity assessed pertains to the newborns born to the enrolled female patients.

The primary outcome is Composite Perinatal Morbidity. Composite morbidity refers to the newborns born to the female participants enrolled in the study. Composite Morbidity is defined as ≥ 1 of the following: respiratory distress syndrome (RDS) (oxygen requirement, clinical diagnosis, and consistent chest radiograph), bronchopulmonary dysplasia (BPD) (requirement for oxygen support at 28 days of life), severe intraventricular hemorrhage (IVH) (grades III or IV), periventricular leukomalacia (PVL), blood culture-proven sepsis present within 72 hours of birth, necrotising enterocolitis (NEC), or perinatal death (stillbirth or neonatal death prior to hospital discharge).

Outcome measures

Outcome measures
Measure
Prelabor Rupture of Membranes Diagnosis on Admission
n=310 Participants
Group who have prelabor rupture of membranes (PROM) are those who break their bag of water prior to 32 weeks gestation in the absence of labor. Diagnosis made on admission
Preterm Labor Diagnosis on Admission
n=263 Participants
Group who goes into labor prior to 32 weeks of gestation. Diagnosis was made on admission
Pre-eclampsia Diagnosis on Admission
n=288 Participants
The diagnosis of Preeclampsia at time of admission
IUGR Diagnosis on Admission
n=59 Participants
The diagnosis of IUGR at time of admission
Vaginal Bleeding Diagnosis on Admission
n=38 Participants
The diagnosis of vaginal bleeding made at time of admission
Short Cervix Diagnosis on Admission
n=37 Participants
The diagnosis of Short cervical length at time of admission
Composite Perinatal Morbidity
Composite Morbidity
277 participants
203 participants
221 participants
45 participants
28 participants
33 participants
Composite Perinatal Morbidity
Serious Morbidity
82 participants
68 participants
62 participants
20 participants
17 participants
20 participants
Composite Perinatal Morbidity
Perinatal (infant) Death
32 participants
20 participants
17 participants
6 participants
5 participants
5 participants
Composite Perinatal Morbidity
Respiratory distress syndrome (RDS)
206 participants
190 participants
211 participants
43 participants
23 participants
27 participants
Composite Perinatal Morbidity
On Ventilatory at 28 days of age
24 participants
28 participants
29 participants
14 participants
11 participants
10 participants
Composite Perinatal Morbidity
Intraventicular Hemorrhage Grade 3 or 4
13 participants
19 participants
8 participants
1 participants
5 participants
8 participants
Composite Perinatal Morbidity
Necrotizing Enterocolitis
9 participants
15 participants
14 participants
3 participants
5 participants
2 participants
Composite Perinatal Morbidity
Periventricular Leukomalacia (PVL)
2 participants
1 participants
1 participants
1 participants
1 participants
0 participants
Composite Perinatal Morbidity
Sepsis
11 participants
5 participants
6 participants
2 participants
1 participants
1 participants
Composite Perinatal Morbidity
Cord arterial pH < 7.1
8 participants
7 participants
14 participants
2 participants
5 participants
0 participants
Composite Perinatal Morbidity
Cord venous pH <7.1
5 participants
5 participants
9 participants
2 participants
3 participants
0 participants
Composite Perinatal Morbidity
Arterial base excess < -12
5 participants
3 participants
6 participants
1 participants
2 participants
0 participants
Composite Perinatal Morbidity
Venous Base Excess < -12
2 participants
4 participants
5 participants
1 participants
2 participants
0 participants
Composite Perinatal Morbidity
Five-minute Apgar score < 5
24 participants
15 participants
15 participants
2 participants
2 participants
6 participants

Adverse Events

Preterm Labor

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Prelabor Rupture of Membranes

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

IUGR Diagnosis on Admission

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Pre-Eclampsia Diagnosis on Admission

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Vaginal Bleeding Diagnosis on Admission

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Short Cervix Diagnosis on Admission

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kimberly Maurel

Mednax. Inc

Phone: 714-593-9171

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place